Press Releases
Post a press release | Manage press releases
-
iVexSol Closes $23.8M Series A-3 Financing
Press release from iVexSol, Inc. • January 26, 2023 -
Vial Partners with RecensMedical in Phase III Clinical Trial to Further Ophthalmology Innovations
Press release from Vial • January 25, 2023 -
The Canadian Alliance for Skills and Training in Life Sciences (CASTL) announces location for Quebec Biomanufacturing Training Facility
Press release from CASTL • January 23, 2023 -
Vial Announces Enrollment of First Patient in Phase II Clinical Trial TLL018-205 for the Treatment of Plaque Psoriasis Sponsored by Highlightll Pharmaceutical
Press release from Vial • January 19, 2023 -
New AAPS-RX Global Collaboration Produces 2-for-1 Registration Deal
Press release from American Association of Pharmaceutical Scientists • January 17, 2023 -
Vial Announces New Central Nervous System Scientific Advisory Board Member, Dr. Jacqueline French of the Epilepsy Study Consortium and NYU Grossman School of Medicine
Press release from Vial • January 12, 2023 -
Former Bayer Executive Jeff Owoc Joins Adapt Ideations
Press release from Adapt Ideations • January 11, 2023 -
The IMA Group Acquires Clinical Trials of America
Press release from The IMA Group • January 11, 2023 -
Sage Bionetworks Appoints New President
Press release from Sage Bionetworks • January 10, 2023 -
Azzur Group Appoints Ming Wang as Director, Consulting Services for Azzur San Francisco
Press release from Azzur Group LLC • January 10, 2023 -
Ymmunobio Appoints Dr. Michel Janicot as Chief Development Officer
Press release from Ymmunobio • January 10, 2023 -
C2i Genomics Announces Successful Evaluation of Whole Genome-Based Residual Disease Test Across Multiple Solid Cancer models
Press release from C2i Genomics • January 05, 2023 -
Vivera Expands TABMELT Global Licensing Reach with Grant of Israel Patent
Press release from Vivera Pharmaceuticals • January 05, 2023 -
Vial Announces the Addition of Dr. Christopher Sweeney of SAiGENCI and the University of Adelaide to their Oncology CRO Scientific Advisory Board
Press release from Vial • December 19, 2022 -
Minicarm.com Expands Their Operations With Their New Mini C-Arm Refurbishment Center
Press release from Minicarm.com • December 19, 2022 -
American Laboratory Trading & Heritage Global Partners to Host Massive Auction of Lab Equipment from Rubius Therapeutics’ Cambridge Facility
Press release from American Laboratory Trading • December 19, 2022 -
Pangea Biomed Adds $5M in Additional Funding for its Multi-Cancer Response Predictor Technology
Press release from Pangea Biomed • December 15, 2022 -
Happy Bob expands to Europe and Canada, integrating with Dexcom CGM to improve patient engagement with real-time glucose values and self-care adherence.
Press release from Harald AI Oy • December 15, 2022 -
Evinature exits stealth with $2 million funding to optimize global healthcare for patients with IBD, Crohn’s, or Colitis through evidence-based natural remedies
Press release from Evinature • December 15, 2022 -
Dr. Peter Goadsby of the NIHR Wellcome Trust at the King's College Clinical Research Facility, London, Joins Vial's Neurology CRO as a Scientific Advisor
Press release from Vial • December 14, 2022
